Hence, Molt4 (T-ALL cell line) xenografted mice were administered TfR-CAR T cells and found that this therapy produced substantial cytotoxicity against the T-ALL line and restrained malignant progression in vivo. This evidence concerns the gene TFRC and acute lymphoblastic leukemia.